3:42 PM Sep 21, 2018

Arrowhead refills its quiver

Arrowhead Pharmaceuticals Inc.’s tox blowup in 2016 set back its clinical timelines, but it also prompted the company to bring a more versatile platform online faster than originally planned....

1:38 PM Sep 21, 2018

Filling the rebate void

HHS’s proposal to eliminate drug rebates should have the intended consequence of increasing transparency into drug pricing in the short term. But the long view is that value-based pricing or...

8:53 PM Sep 20, 2018

China’s rising genomics start-ups

Behind bellwethers BGI Genomics Co. Ltd. and WuXi NextCode Genomics Inc., a new generation of Chinese genomics companies is emerging with ambitions to solve urgent problems, including early cancer...

6:21 PM Sep 20, 2018

Precision for pancreatic cancer

Real-time sequencing and organoid-based screens in pancreatic cancer could place new targets and biomarkers in the hands of drug developers looking for ways to side-step KRAS, a gene mutated in...

7:37 PM Sep 13, 2018

Academia’s manufacturing problem

With backups at academic manufacturing centers beginning to hamper translation of early stage gene therapies, pushing those who can afford it to CMOs, at least one non-profit has stepped in with a...

1
2
3
4
5

Latest News

3:29 PM Sep 21, 2018

Management tracks: Ex-MiMedx execs to lose compensation

MiMedx Group Inc. (NASDAQ:MDXG) said it will treat four resignations announced this summer, including that...

3:27 PM Sep 21, 2018

Stanford team identifies human skeletal stem cells

The discovery of self-renewing human skeletal stem cells by Stanford University researchers takes the...

3:15 PM Sep 21, 2018

GTx shares crater after incontinence readout

GTx Inc. (NASDAQ:GTXI) shed 92% of its value Friday, falling from the small cap band to trading at roughly...

2:57 PM Sep 21, 2018

Innovent reports Chinese NET, NSCLC data for PD-1 mAb

Innovent Biologics Inc. (Suzhou, China) presented data this week from neuroendocrine tumor and non-small...

2:45 PM Sep 21, 2018

CHMP backs Luxturna, Lilly's migraine mAb, antibiotic Vabomere

EMA's CHMP Friday recommended several therapies for approval, including gene therapy Luxturna voretigene...

12:33 PM Sep 21, 2018

FDA panel to discuss how patients can improve medical device review

FDA's Patient Engagement Advisory Committee (PEAC) will meet Nov. 15 to discuss how the agency can...

6:33 AM Sep 21, 2018

Follow-on roundup: CRISPR, Viking, Fate, Molecular Templates

CRISPR Therapeutics AG (NASDAQ:CRSP), Viking Therapeutics Inc. (NASDAQ:VKTX), Fate Therapeutics Inc. (...

4:00 AM Sep 21, 2018

uBiome moving into therapeutics with $83M series C

Microbiome tech and diagnostic company uBiome Inc. (San Francisco, Calif.) raised $83 million in a series...

4:53 PM Sep 20, 2018

First-day pop for Y-mAbs after upsized $96M IPO

Cancer company Y-mAbs Therapeutics Inc. (NASDAQ:YMAB) gained $8 (50%) to $24 on Friday after raising $96...

4:14 PM Sep 20, 2018

Celenex takeout first of several planned gene therapy deals for Amicus

Just weeks after gaining its first FDA approval, Amicus Therapeutics Inc. (NASDAQ:FOLD) has announced its...

4:13 PM Sep 20, 2018

Opiant gets BARDA grant for intranasal opioid antagonist

HHS partnered with Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) to accelerate development of the company's...

3:35 PM Sep 20, 2018

Management tracks: Garland to lead Portola; Gallagher joining Abingworth

Hematology company Portola Pharmaceuticals Inc. (NASDAQ:PTLA) hired Scott Garland as president and CEO. He...

2:08 PM Sep 20, 2018

FDA may crack down on clinical trial reporting

FDA is signaling that it may start fining clinical trial sponsors if they fail to meet legal requirements...

1:36 PM Sep 20, 2018

FDA: No new safety concerns for Acadia's PD psychosis drug

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) rose $4.01 (27%) to $19.11 on Thursday, adding more than $500...

12:52 PM Sep 20, 2018

Roxadustat meets in Phase III for CKD patients with anemia not on dialysis

Astellas Pharma Inc. (Tokyo:4503) said roxadustat (ASP1517, FG-4592) met both primary endpoints in the...

11:00 AM Sep 20, 2018

Ex-FDA Chief Hamburg says AAAS will take on harassment

The scientific community urgently needs systemic changes that address sexual and gender-based harassment,...

6:56 AM Sep 20, 2018

RNA-modifying enzyme loops mRNA to increase oncogene translation

Boston Children's Hospital researchers showed interaction between a translation factor and RNA-modifying...

6:46 AM Sep 20, 2018

DePinho's STAT3 company Tvardi raises $9M series A

Tvardi Therapeutics Inc. (Houston, Texas) raised $9 million in a series A round from Alexandria Venture...

4:07 PM Sep 19, 2018

Management tracks: GSK adds Corsico, Enzmann to chair CHMP

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) hired Chris Corsico, CMO of Boehringer Ingelheim GmbH (Ingelheim,...

3:56 PM Sep 19, 2018

NICE wavers on end of life exception for DLBCL CAR Ts, says Kymriah doesn't meet criteria

Inconsistencies between appraisals by U.K.'s NICE of CAR T therapies emerged Wednesday after the committee...

Down Up